Flow Cytometry of Hematological Malignancies

Name: Flow Cytometry of Hematological Malignancies
Brand: Wiley
Price: 170.99 EUR
Availability: OnlineOnly

Claudio Ortolani(Autor*in)

Wiley (Verlag)

2. Auflage

Erschienen am 19. April 2021

464 Seiten

E-Book

ePUB mit Adobe-DRM

Systemvoraussetzungen

978-1-119-61130-1 (ISBN)

170,99 €inkl. 7% MwSt.

Systemvoraussetzungen

für ePUB mit Adobe-DRM

E-Book Einzellizenz

Als Download verfügbar

Beschreibung

Weitere Details

Weitere Ausgaben

Person

Inhalt

Cover
Title Page
Copyright Page
Contents
Foreword to the Second Edition
Foreword to the First Edition
Foreword to the First Edition
Preface to the Second Edition
Preface to the First Edition
Abbreviations
Chapter 1 Antigens
CD1 Antigens
CD2 Antigen
CD3 Antigen
CD4 Antigen
CD5 Antigen
CD7 Antigen
CD8 Antigen
CD10 Antigen
CD11b Antigen
CD11c Antigen
CD13 Antigen
CD14 Antigen
CD15 Antigen
CD16 Antigen
CD19 Antigen
CD20 Antigen
CD22 Antigen
CD23 Antigen
CD24 Antigen
CD25 Antigen
CD26 Antigen
CD27 Antigen
CD28 Antigen
CD30 Antigen
CD33 Antigen
CD34 Antigen
CD38 Antigen
CD43 Antigen
CD45 Antigen
CD45 Isoforms
CD49 Antigens
CD56 Antigen
CD57 Antigen
CD61 Antigen
CD62L Antigen
CD64 Antigen
CD65 Antigen
CD66c Antigen
CD71 Antigen
CD79 Antigen
CD81 Antigen
CD103 Antigen
CD117 Antigen
CD123 Antigen
CD138 Antigen
CD200 Antigen
CD305 Antigen
CD307 (IRTA) Family
CD371 Antigen
BCL-2 Protein
Chemokines and Chemokine Receptors
Chemokines
Chemokine Receptors
CRLF2 Antigen
Cytotoxic Proteins
HLA-DR Antigen
Immunoglobulins
KIRs, CD158 Isoforms
Myeloperoxidase
NG2 Antigen
PCA-1 Antigen
ROR1 Antigen
SLAM Molecules and SLAM-Associated Protein
SOX11
T-Cell Receptor (TCR)
Terminal Deoxy-Nucleotidyl Transferase
Toll-Like Receptors
VS38 Antigen
ZAP-70 Protein
Chapter 2 Diseases
Myeloproliferative neoplasms
Chronic myeloid leukemia (CML)
Myeloproliferative neoplasms other than CML
Chronic neutrophilic leukemia (CNL)
Polycythemia vera (PV)
Primary myelofibrosis (PMF)
Essential thrombocythemia (ET)
Chronic eosinophilic leukemia (CEL)
Mastocytosis
Acute mast-cell leukemia (AMCL)
Chronic mast-cell leukemia (CMCL)
Myelomastocytic leukemia (MML)
Myelodysplastic/myeloproliferative neoplasms
Chronic myelomonocytic leukemia (CMML)
Other myelodysplastic/myeloproliferative neoplasms and related conditions
Juvenile myelomonocytic leukemia (JMML)
Atypical CML bcr/abl negative (ACML)
RAS-associated autoimmune leukoproliferative disorder (RALD)
Myelodysplastic syndromes
Myeloid neoplasms with germline predisposition
Acute myeloid leukemias
AMLs with recurrent genetic anomalies
AMLs with chromosomal anomalies
AMLs with gene mutations
Relationships between genotype and phenotype in cases of AML not recognized as separate entities in WHO 2017
AMLs with myelodysplasia-related changes (AML-MRC)
AMLs not otherwise specified
AML with minimal differentiation
AML without maturation
AML with maturation
Acute myelomonocytic leukemia (AMMoL)
Acute monoblastic and monocytic leukemia (AMoL)
Pure erythroid leukemia (PEL)
Acute megakaryoblastic leukemia (AMKL)
Acute basophilic leukemia (ABL)
Myeloid proliferations associated with Down syndrome
Transient abnormal myelopoiesis (TAM)
AMLs in patients with Down syndrome
Blastic plasmacytoid dendritic cell neoplasm (BPDCN/PDCL)
Acute leukemias with ambiguous lineage attribution (ALAL)
Acute undifferentiated leukemias (AUL)
Mixed phenotype acute leukemias (MPAL)
Neoplastic diseases of B and T lymphatic precursors
B lymphoblastic leukemia/lymphoma, not otherwise specified (B-ALL/LBLnos)
B lymphoblastic leukemia/lymphoma with recurrent genetic anomalies
Relationships between genotype and phenotype in cases of B-ALL not recognized as separate entities in WHO 2017
T lymphoblastic leukemia/lymphoma (T-ALL/LBL)
Early T-cell precursor lymphoblastic leukemia (ETP-ALL)
NK lymphoblastic leukemia/lymphoma (NK-ALL/LBL)
Neoplastic diseases of mature B cells
Chronic lymphocytic leukemia/small lymphocytic lymphoma (B-CLL/SLL)
Familial B-CLL
Richter syndrome
Monoclonal B-cell lymphocytosis (MBL)
CLL-like monoclonal B lymphocytosis
Non-CLL-like monoclonal B lymphocytosis
B-cell prolymphocytic leukemia (B-PLL)
Lymphoplasmacytic lymphoma (LPL)
Heavy chain disease (HCD)
µ heavy chain disease
a heavy chain disease
Hairy cell leukemia (HCL)
Hairy cell leukemia, variant (HCL-v)
Hairy cell leukemia, Japanese variant (HCL-J)
Splenic diffuse red pulp lymphoma (SDRPL)
Marginal zone lymphomas (MZL)
Nodal marginal zone lymphoma (NMZL)
Splenic marginal zone lymphoma (SMZL)
Extranodal marginal zone lymphoma (EMZL/MALToma)
Clonal B-cell lymphocytosis with MZL-like phenotype (CBL-MZ)
Follicular lymphoma (FCL)
Testicular follicular lymphoma
Duodenal type follicular lymphoma
Pediatric type follicular lymphoma
Primitive cutaneous follicular lymphoma (PCFL)
Large B-cell lymphoma with IRF4 rearrangement
Mantle-cell lymphoma (MCL)
Blastic mantle-cell lymphoma (BMCL)
Leukemic non nodal mantle-cell lymphoma
DLBCL not otherwise specified (DLBCLnos)
CD5(+) diffuse large cell lymphoma (CD5(+) DLBCL)
T-cell/histiocyte-rich B-cell lymphoma (THRLBCL)
Primary DLBCL of the CNS (PCNSL)
Primary cutaneous DLBCL, "leg type
EBV(+) DLBCLnos
DLBCL associated with chronic inflammation (PAL)
Fibrin associated DLBCL
Lymphomatoid granulomatosis (LYG)
Primary mediastinal B-cell lymphoma (PMBCL)
Intravascular large B-cell lymphoma (IVBCL)
ALK-positive large cell lymphoma (ALK(+) LBCL)
Plasmablastic lymphoma (PBL)
Primary effusion lymphoma (PEL)
HHV8-associated lymphoproliferative disorders
HHV8-positive DLBCL
HHV8-positive germinotropic lymphoproliferative disorder
Burkitt lymphoma (BL)
Burkitt leukemia with immature phenotype
Burkitt-like lymphoma with 11q aberrations
High-grade B-cell lymphoma (HGBL)
Plasma cell neoplasms
Monoclonal gammopathies of undetermined significance (MGUS)
Multiple myeloma (MM)
Plasma cell leukemia (PCL)
Neoplastic diseases of mature T and NK cells
T-cell prolymphocytic leukemia (T-PLL)
T-cell large granular lymphocytic leukemia (T-LGL)
Chronic lymphoproliferative disorders of NK cells (CLPD-NK/CNKL)
Aggressive NK-cell leukemia (ANKL)
Adult T-cell leukemia/lymphoma (ATLL)
Extranodal NK/T-cell lymphoma, "nasal type" (ENKTL)
Intestinal T-cell lymphomas (ITCL)
Enteropathy-associated T-cell lymphoma (EATCL)
Monomorphic epitheliotropic intestinal T-cell lymphoma (MEITL)
Indolent gastro-intestinal T lymphoproliferative disorder (indolent GI T-LPD)
Hepatosplenic T-cell lymphoma (HSTCL)
Subcutaneous panniculitis-like T-cell lymphoma (SPTCL)
Mycosis fungoides (MF)
Sezary syndrome (SS)
Primary cutaneous CD30(+) lymphoproliferative disorders
Lymphomatoid papulosis (LyP)
Primary cutaneous anaplastic T-cell lymphoma (pcALCL)
Primary cutaneous peripheral T-cell lymphoma (PTCL)
Primary cutaneous TCRƒÁƒÂ(+) T-cell lymphoma (PCGD-TCL)
Primary cutaneous CD8(+) aggressive epidermotropic cytotoxic T-cell lymphoma (PCAETL)
Primary cutaneous acral CD8(+) T-cell lymphoma (PCATCL)
Primary cutaneous lymphoma of the medium/small CD4(+) T cells (PCSM-TCL)
Peripheral T-cell lymphoma, not otherwise specified (PTCLnos)
Nodal lymphomas of follicular T-helper derivation
Angioimmunoblastic T-cell lymphoma (AITL)
Follicular T-cell lymphoma (FTCL)
Nodal PTCL with follicular T-helper phenotype
Anaplastic large cell lymphoma ALK(+) (ALCL ALK(+))
Anaplastic large cell lymphoma ALK(-) (ALCL ALK(-))
Breast implant.associated anaplastic large cell lymphoma (biaALCL)
Hodgkin lymphomas
Classic Hodgkin lymphoma (CHL)
Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL)
Neoplastic diseases of histiocytic and dendritic cells
Histiocytic sarcoma (HS)
Langerhans cell histiocytosis (LCH)
Indeterminate dendritic cell tumor (IDCT)
Interdigitating dendritic cell sarcoma (IDCS)
Follicular dendritic cell sarcoma (FDCS)
Erdheim.Chester disease (EDC)
Chapter 3 Appendix
Acute leukemias not recognized by the 2017 WHO classification
Acute leukemia of myeloid/NK precursors (M/NK-AL)
Acute leukemia of myeloid dendritic cells (MDCL)
Acute leukemia of Langerhans cells
Composite lymphomas
Hypereosinophilic syndrome (HES), lymphocyte variant
Indolent T lymphoblastic proliferations (iT?]LBP)
Polyclonal lymphocytoses of B lymphocytes
Persistent polyclonal B?]cell lymphocytosis (PPBL)
Persistent polyclonal CD5(+) B?]cell lymphocytosis
Persistent polyclonal B?]cell lymphocytosis, Japanese (hairy) variant
Polyclonal plasmacytoses
Small round (blue) cell tumors (SR(B)CT)
References
Index
EULA

Abbreviations

3-FAL: 3-fucosyl-N-acetyllactosamine
ABC: antibody-binding capacity
ABC: age/autoimmune-associated B cell
ABC-like: activated B-cell like
a-B-CLL: Atypical B-cell chronic lymphatic leukemia
ABL: acute basophilic leukemia
acPGP: N-acetyl Proline-Glycine-Proline
aCML: atypical chronic myeloid leukemia
ADA: adenosine deaminase
ADP: adenosine diphosphate
AITL: angioimmunoblastic T-cell lymphoma
aka: also known as
ALAL: acute leukemia of ambiguous lineage
ALALnos: acute leukemia of ambiguous lineage not otherwise specified
ALCL: anaplastic large cell lymphoma
ALDH: aldehyde dehydrogenase
ALK: anaplastic lymphoma kinase
ALL: acute lymphoblastic leukemia
ALPS: autoimmune lymphoproliferative syndrome
AMCL: acute mast cell leukemia
AMKL: acute megakaryoblastic leukemia
AML: acute myeloid leukemia
AMLL: acute mixed lineage leukemia
AML-MRC: AML with myelodysplasia-related changes
AMM: agnogenic myeloid metaplasia
AMoL: acute monoblastic and monocytic leukemia
ANKL: aggressive NK-cell leukemia
ANXA-1: Annexin-1
APC: antigen-presenting cell
APL: acute promyelocytic leukemia
ASM: aggressive systemic mastocytosis
ATLL: adult T-cell leukemia/lymphoma
atMSC: adipose-tissue-derived mesenchymal stromal cells
ATRA: all-trans retinoic acid
AUL: acute undifferentiated leukemia
AZT: azidothymidine (zidovudine)
BALF: bronchoalveolar lavage fluid
B-ALL: B-cell acute lymphoblastic leukemia
BCL: B-cell lymphoma (gene)
B-CLL: B-cell chronic lymphocytic leukemia
B-CLL/LPL: B-CLL in lymphoplasmacytoid transformation
B-CLL/PL: B-CLL in prolymphocytoid transformation
B-CLPD: B-cell chronic lymphoproliferative disease
BCR: B-cell receptor
BFU-E: burst-forming units/erythroid
biaALCL: breast implant-associated anaplastic large cell lymphoma
BIM: bcl-2-interacting mediator of cell death
BL: Burkitt lymphoma
B-LBL: B-cell lymphoblastic lymphoma
BM: bone marrow
B-NHL: B-cell non-Hodgkin lymphoma
BPDCN: blastic plasmacytoid dendritic cell neoplasm
B-PLL: B-cell prolymphocytic leukemia
B-SLL: B-cell small lymphocytic lymphoma
BVMCL: blastic variant mantle-cell lymphoma
C9RP: complement 9 related protein
CA I: carbonic anhydrase isoenzyme I
CBCL: cutaneous B-cell lymphoma
CBL-MZ: clonal B-cell lymphocytosis of marginal zone origin
CCND1: cyclin D1
CEA: carcinoembryonic antigen
CEL: chronic eosinophilic leukemia
CEL nos: chronic eosinophilic leukemia not otherwise specified
CFU: colony-forming unit
CFU-EO: colony-forming unit/eosinophil
CFU-G: colony-forming unit/granulocyte
CFU-GEMM: colony-forming unit/granulocyte, erythrocyte, monocyte, megakaryocyte
CFU-GM: colony-forming unit granulocyte-macrophage
CFU-M: colony-forming unit/macrophage
CGH: comparative genomic hybridization
CHL: classic Hodgkin lymphoma
CINCA: chronic infantile neurological cutaneous articular syndrome
CLA: cutaneous lymphocyte antigen
CLPD: chronic lymphoproliferative disease
CLPD-NK: chronic lymphoproliferative disorders of NK cells
CM: cutaneous mastocytosis
CMCL: chronic mast cell leukemia
CML: chronic myeloid leukemia
CML-BC: CML in blastic crisis
CMML: chronic myelomonocytic leukemia
CMPD: chronic myeloproliferative disease
CMPN: chronic myeloproliferative neoplasm
CMV: cytomegalovirus
CNKL: chronic NK cell lymphocytosis
CNL: chronic neutrophilic leukemia
CNS: central nervous system
CPLD: chronic lymphoproliferative disease
CRLF2: cytokine receptor-like factor 2
CRS: chemokine receptor status
CSF: cerebrospinal fluid
CSR: class switch recombination
CTCL: cutaneous T-cell lymphoma
CY5.5: cyanine 5.5
CY7: cyanine 7
cyµ: cytoplasmic µ heavy chain
DFS: disease-free survival
DH-JH: diversity and joining segments of the Ig heavy chain gene
DHL: double-hit B-cell lymphoma
DLBCL: diffuse large B-cell lymphoma
DLBCLnos: diffuse large B-cell lymphoma not otherwise specified
DLBCL-SS: sanctuary site DLBCL
DPP IV: dipeptidyl peptidase-IV
DRESS: DRug-induced Eosinophilia with Systemic Symptoms
EATCL: enteropathy-associated T-cell lymphoma
EBER: Epstein-Barr virus-encoded RNA
EBV: Epstein-Barr virus
ECD: Erdheim-Chester disease
EFS: event-free survival
EGIL: European Group for the Immunological Characterization of Leukemias
EMA: epithelial membrane antigen
EML: extramedullary myeloid leukemia
EMZL: extranodal marginal zone lymphoma
ENKTL: extranodal NK/T-cell lymphoma
EPC: endothelial progenitor cells
ET: essential thrombocythemia
ETP: early T-cell precursor
FAB: French-American-British
FCCL: follicular cell cutaneous lymphoma
FCL: follicular lymphoma
FCM: flow cytometry
FcRH: Fc receptor homologues
FCRL: Fc receptor-like proteins
FDC: follicular dendritic cell
FDCS: follicular dendritic cell sarcoma
FISH: fluorescence in situ hybridization
FITC: fluorescein isothiocyanate
FL: follicular lymphoma
FLT3: fms-related tyrosine kinase 3 (CD135)
FLT3-ID: FLT3 internal tandem duplication
FOXP: FOX (forkhead box) protein
FSC: forward scatter
FTCL: follicular T-cell lymphoma
FTH: follicular helper T cells
FUT: fucosyl-transferase
GCB-like: germinal center B-cell like
GCC: germinal center cell
G-CSF: granulocyte-colony stimulating factor
GEP: gene expression profile
GLPD: germinotropic lymphoproliferative disorder
GM-CSF: granulocyte-macrophage colony-stimulating factor
HABP4: hyaluronan binding protein 4
HAL: hybrid acute leukemia
HBME-1: human bone marrow endothelium marker-1
HBLD: hairy B-cell lymphoproliferative disorder
HCD: heavy chain disease
HCL: hairy cell leukemia
HCL-J: hairy cell leukemia, Japanese variant
HCL-v: hairy cell leukemia, variant
HCV: hepatitis C virus
HE: hematoxylin-eosin
HES: hypereosinophilic syndrome
HEV: high endothelial venules
HGAL protein: human germinal center-associated lymphoma protein
HGBL: high-grade B-cell lymphoma
HGL: high-grade lymphoma
HLH: hemophagocytic lymphohistiocytosis
HN: hematodermic neoplasm
HPC: hemopoietic precursor cell
HRS: Hodgkin and Reed-Sternberg
HS: histiocytic sarcoma
HSTCL: hepatosplenic T-cell lymphoma
HUMARA: human androgen receptor
ICOS: inducible T-cell COStimulator (CD278)
IDCS: interdigitating dendritic cell sarcoma
IDCT: indeterminate dendritic cell tumor
IEL: intraepithelial intestinal lymphocyte
Ig: immunoglobulin
i-GIT-T-LPD: indolent T-cell lymphoproliferative disorder of the gastrointestinal tract
IHC: immunohistochemistry
IL: interleukin
iNK: immature...

Systemvoraussetzungen

Als PDF speichern Als Link merken